Document is current
Any future updates will be listed below
-
Authors
Chapman, A
Bardsley, E
Card, H
Marshall, E
Olsson-Brown, A
- License Information
-
More Information
Article History
Received: 12 May 2023
Accepted: 7 November 2023
First Online: 5 December 2023
Declarations
:
: A Chapman, E Bardsley and H Card have no relevant financial or non-financial interests to disclose. E Marshall declares he is current acting chair of the UK Acute Oncology Society. A Olsson-Brown reports speaking honoraria from the BMS, MSD, Eisai, Novartis, Bo-In, Roche and Astra Zeneca; previous research funding from the UCB pharma, Roche, Eli Lily and Novartis; travel expenses from the Ipsen and an education grant from the BMS.
